
CLEVELAND, May 4 (UPI) -- Cleveland Clinic heart doctors have voted unanimously to severely curtail or even ban the clinic's use of Johnson & Johnson drug Natrecor.
Widely used as a treatment for heart failure, Natrecor has been reported in two recent medical journal studies to increase kidney problems and death rates among patients, the New York Times reported Wednesday.
A clinic committee was set to review the vote Wednesday. A Johnson & Johnson spokesman, said the company would not speculate on the outcome of the committee's review.
"From our perspective, Natrecor is highly effective and has a positive risk-benefit ratio when used in patients with acutely decompensated heart failure, a life-threatening condition for which there are limited treatment options," said Mark Wolfe.
Natrecor is approved to treat severe cases of acute heart failure and also has been widely used in outpatient clinics where patients arrive for regular infusions. As a result, as many as 600,000 patients have been treated with the drug since its 2001 approval.
Johnson & Johnson gained ownership of Natrecor in 2003 when it bought Scios, a biotechnology company.
|
|
|
|
|
|
| Additional Science News Stories | |
BOSTON, May 31 (UPI) --
A U.S. appeals court panel in Boston ruled Thursday that the federal Defense of Marriage Act cannot affect gay marriages in states that permit them.
|
OSLO, Norway, May 31 (UPI) --
Dozens of teenage girls suffered minor injuries during a stampede at a Justin Bieber concert in Oslo, Norway, officials said Thursday.
|
BALTIMORE, May 31 (UPI) --
U.S. astronomers are forecasting the Milky Way will have a violent collision with the neighboring Andromeda galaxy in about 4 billion years.
|
NORTHAMPTON, Mass., May 31 (UPI) --
A Massachusetts woman said she investigated bird sounds in her yard and discovered a baby cardinal with two heads and three beaks.
|
| Stories | Photos | People | Comments |
View Caption